
VCAST is an AI-powered platform that derives functional coronary data – fractional flow reserve, energy flow reserve, and plaque burden – from standard CTCA. No pressure wire. No stress agent. No additional acquisition.

FFR remains the gold standard – but measuring it requires a pressure wire inside the coronary artery. Only 6% of eligible patients receive it. The procedure carries cost, cathlab access, and procedural risk.
CT angiography shows anatomy – lumen width, plaque location. It does not show flow. A 70% stenosis on imaging may be haemodynamically insignificant, or a 50% stenosis may be the one causing ischaemia. Anatomy alone cannot decide.
Nuclear stress tests, echo stress, and cathlab FFR add days or weeks to the diagnostic pathway. Each step occupies capital equipment, specialist time, and increases patient exposure. The pathway fragments across departments.
VCAST is a patented, AI-based medical system that performs non‑invasive, quantitative analysis of standard CTCA data. It produces fractional flow reserve (FFR), energy flow reserve (EFR), and plaque burden – the functional data normally reserved for the catheterisation laboratory – without pressure wires, stress agents, or specialist intervention.
The only input required is a standard CT acquisition. No modified protocol. No additional equipment. Any scanner, any vendor, any imaging protocol.
A standard non-invasive CT scan
No extra acquisition
AI segmentation, verification + CFD simulation.
Everything in cloud
FFR, EFR, plaque burden – 3D models
With access on every mobile device
Any CT manufacturer, any protocol
Fully agnostic
From acquisition to interactive report… with radiologists in the loop

A standard non-invasive CT – the only input VCAST requires. Independent of scanner type or imaging protocol.

Upload directly or stream from your PACS via the VCAST API. Metadata extracted automatically.

A proprietary cloud algorithm reconstructs a full 3D coronary model from 2D slices in minutes.

A team of radiologists reviews and signs off on every segmentation. AI does the lift, humans approve.

Computational fluid dynamics simulate pressure, velocity and FFR across every named segment.

A full report, with embedded 3D models, reaches the physician through QR or web – wherever they read.
No catheters, no stress agents. The CT they already had is enough.
Auto-scales with caseload. No on-premise hardware. No additional infrastructure. Simple, powerful and intuitive. It only takes 5 minutes to learn and start working.
FFR, EFR, stenosis grade – in one colour-coded viewer available on any mobile device. The data normally available only from the cathlab.
AI performs segmentation autonomously. A radiologist reviews and signs off every case before results are released.
Stream DICOMs directly from your PACS – no downloads, no manual file transfer. Compatible with any vendor and any imaging protocol.
CE-marked under MDR. Coding and reimbursement guidance available for target markets. Contact us for country-specific information.


VCAST is supported by published research, multi-centre validation, and reimbursement guidelines in our target markets. We share the full evidence dossier on request.
The Comparative Method Based on Coronary Computed Tomography Angiography for Assessing the Hemodynamic Significance of Coronary Artery Stenosis.
The full white paper – methodology, validation and example procedure.

The aim is to create an innovative diagnostic tool for the automatic detection and assessment of atherosclerotic plaques – a solution currently unavailable on the market. Supporting the project through PARP financing will enable the creation of an innovative product that can be a pioneer on the global market.
The VCAST report delivers per-vessel FFR, EFR in a colour-coded 3D viewer – accessible via browser or QR code from the printed report. No dedicated workstation required.
VCAST provides precise hemodynamic assessment of the coronary artery tree with simultaneous accessible, interactive 3D visualization, which can be easily and safely shared with the patient and other doctors in the form of a QR code.
Konrad Pieszko
Physician · Research Scientist
When we compared VCAST results with invasive FFR measurements, they were consistent, which shows that the method is reliable and can reduce the need for invasive procedures. And since it's a SaaS solution, integration is fast, which keeps costs low for the hospitals.
Michael Nettelbladt
NexGenMediq
VCAST offers a precise, non-invasive diagnostic tool that can detect significant changes in blood flow at an early stage, before serious symptoms of coronary artery disease appear.
Zbigniew Małota
Head of Biocybernetics Laboratory · Zbigniew Religa Foundation for the Development of Cardiac Surgery
~15 minutes
5,000+
0.01
2,000+

Book a 30-minute call with us.
Prepare a de-identified CT case — we'll process it
for you so you can see the result
A live analysis on demo CT
Full 3D viewer walkthrough
Integration & reimbursement Q&A
Evidence dossier bundle